A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.

about

Modelling Structure Activity Landscapes with Cliffs: a Kernel Regression-Based Approach.

P2860

Q39535142-69AB06CC-F283-4948-88F2-8AC67E2C56C5

P2860

A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.

Item

http://www.wikidata.org/entity/Q39541058

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.

@en

A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.

@nl

type

Item

label

A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.

@en

A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.

@nl

prefLabel

A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.

@en

A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.

@nl

P1476

A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions

@en

P2093

Cleo Tebby

http://www.w3.org/2001/XMLSchema#string

Enrico Mombelli

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of prediction confidence and domain extrapolation of two structure-activity relationship models for predicting estrogen receptor binding activity

Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic as

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents

On Estimating Regression

A Risk Assessment Perspective of Current Practice in Characterizing Uncertainties in QSAR Regression Predictions.

Global Validation of Linear Model Assumptions.

The CAESAR project for in silico models for the REACH legislation.

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK properties.

P304

741-751

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MINF.201200053

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Enrico Mombelli

Cleo Tebby

P577

2012-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27476456

http://www.w3.org/2001/XMLSchema#string

A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.

about

P2860

P2860

A Kernel-Based Method for Assessing Uncertainty on Individual QSAR Predictions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698